Publication | Closed Access
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry
245
Citations
14
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1